CSIR India and Laxai Life Sciences initiate clinical trials of promising repurposed drug Niclosamide…
GG News Bureau
New Delhi, 6th June. CSIR in collaboration with Laxai Life Sciences Pvt. Ltd., has initiated Phase-II clinical trial with anti-helminthic drug Niclosamide for treatment of Covid-19. The trial is a multi-centric, phase-II,…